2018-2025 Orexin Receptor Type 2 Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

Published On: Dec 2018

Format: PDF

Publisher: QY Research

Pages: 124

Report ID: 210700

Summary

This report studies the Orexin Receptor Type 2 market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Orexin Receptor Type 2 market by product type and application/end industries.

The global Orexin Receptor Type 2 market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Orexin Receptor Type 2.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Orexin Receptor Type 2 in these regions, from 2013 to 2025 (forecast), covering
United States
North America
Europe
Asia-Pacific
South America
Middle East and Africa

The major players in global and United States market, including
Actelion Pharmaceuticals Ltd
Eisai Co Ltd
Evotec AG
Heptares Therapeutics Ltd
Idorsia Ltd
Johnson & Johnson
Merck & Co Inc
OptiNose US Inc
Yangtze River Pharmaceutical Group
On the basis of product, the market is primarily split into
HTL-6641
MK-8133
Lemborexant
OPN-021
YNT-185
Others
On the basis on the end users/application, this report covers
Insomnia
Narcolepsy
Sleep Disorders
Major Depressive Disorder

Table of Contents

2018-2025 Orexin Receptor Type 2 Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer

2 Orexin Receptor Type 2 Market Overview
2.1 Orexin Receptor Type 2 Product Overview
2.2 Orexin Receptor Type 2 Market Segment by Type
2.2.1 HTL-6641
2.2.2 MK-8133
2.2.3 Lemborexant
2.2.4 OPN-021
2.2.5 YNT-185
2.2.6 Others
2.3 Global Orexin Receptor Type 2 Product Segment by Type
2.3.1 Global Orexin Receptor Type 2 Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
2.3.2 Global Orexin Receptor Type 2 Sales (K Pcs) and Market Share (%) by Type (2013-2018)
2.3.3 Global Orexin Receptor Type 2 Revenue (Million USD) and Market Share (%) by Type (2013-2018)
2.3.4 Global Orexin Receptor Type 2 Price (USD/Pcs) by Type (2013-2018)
2.4 United States Orexin Receptor Type 2 Product Segment by Type
2.4.1 United States Orexin Receptor Type 2 Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
2.4.2 United States Orexin Receptor Type 2 Sales (K Pcs) and Market Share by Type (2013-2018)
2.4.3 United States Orexin Receptor Type 2 Revenue (Million USD) and Market Share by Type (2013-2018)
2.4.4 United States Orexin Receptor Type 2 Price (USD/Pcs) by Type (2013-2018)

3 Orexin Receptor Type 2 Application/End Users
3.1 Orexin Receptor Type 2 Segment by Application/End Users
3.1.1 Insomnia
3.1.2 Narcolepsy
3.1.3 Sleep Disorders
3.1.4 Major Depressive Disorder
3.2 Global Orexin Receptor Type 2 Product Segment by Application
3.2.1 Global Orexin Receptor Type 2 Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
3.2.2 Global Orexin Receptor Type 2 Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Orexin Receptor Type 2 Product Segment by Application
3.3.1 United States Orexin Receptor Type 2 Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
3.3.2 United States Orexin Receptor Type 2 Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 Orexin Receptor Type 2 Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Orexin Receptor Type 2 Market Size and CAGR by Regions (2013, 2017 and 2025)
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.1.7 United States
4.2 Global Orexin Receptor Type 2 Sales and Revenue by Regions
4.2.1 Global Orexin Receptor Type 2 Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
4.2.2 Global Orexin Receptor Type 2 Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
4.2.3 Global Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.4 North America Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.5 Europe Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.6 Asia-Pacific Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.7 South America Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
4.2.8 Middle East and Africa Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.9 United States Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 Global Orexin Receptor Type 2 Market Competition by Players/Manufacturers
5.1 Global Orexin Receptor Type 2 Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Orexin Receptor Type 2 Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Orexin Receptor Type 2 Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Orexin Receptor Type 2 Manufacturing Base Distribution, Sales Area, Product Types
5.5 Orexin Receptor Type 2 Market Competitive Situation and Trends
5.5.1 Orexin Receptor Type 2 Market Concentration Rate
5.5.2 Global Orexin Receptor Type 2 Market Share (%) of Top 3 and Top 5 Players
5.5.3 Mergers & Acquisitions, Expansion

6 United States Orexin Receptor Type 2 Market Competition by Players/Manufacturers
6.1 United States Orexin Receptor Type 2 Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Orexin Receptor Type 2 Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Orexin Receptor Type 2 Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Orexin Receptor Type 2 Market Share (%) of Top 3 and Top 5 Players


7 Orexin Receptor Type 2 Players/Manufacturers Profiles and Sales Data
7.1 Actelion Pharmaceuticals Ltd
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Orexin Receptor Type 2 Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.1.4 Main Business/Business Overview
7.2 Eisai Co Ltd
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Orexin Receptor Type 2 Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Eisai Co Ltd Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.2.4 Main Business/Business Overview
7.3 Evotec AG
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Orexin Receptor Type 2 Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Evotec AG Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.3.4 Main Business/Business Overview
7.4 Heptares Therapeutics Ltd
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Orexin Receptor Type 2 Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Heptares Therapeutics Ltd Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.4.4 Main Business/Business Overview
7.5 Idorsia Ltd
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Orexin Receptor Type 2 Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Idorsia Ltd Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.5.4 Main Business/Business Overview
7.6 Johnson & Johnson
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Orexin Receptor Type 2 Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Johnson & Johnson Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.6.4 Main Business/Business Overview
7.7 Merck & Co Inc
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Orexin Receptor Type 2 Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Merck & Co Inc Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.7.4 Main Business/Business Overview
7.8 OptiNose US Inc
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Orexin Receptor Type 2 Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 OptiNose US Inc Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.8.4 Main Business/Business Overview
7.9 Yangtze River Pharmaceutical Group
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Orexin Receptor Type 2 Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.9.4 Main Business/Business Overview

8 Orexin Receptor Type 2 Manufacturing Cost, Industrial Chain and Downstream Buyers
8.1 Orexin Receptor Type 2 Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Orexin Receptor Type 2 Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 Marketing Strategy Analysis, Distributors and Market Effect Factors
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
9.3.1 Economic/Political Environmental Change
9.3.2 Downstream Demand Change
9.3.3 Technology Progress in Related Industry
9.3.4 Substitutes Threat

10 Global Orexin Receptor Type 2 Market Forecast
10.1 Global Orexin Receptor Type 2 Sales, Revenue Forecast (2018-2025)
10.1.1 Global Orexin Receptor Type 2 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.1.2 Global Orexin Receptor Type 2 Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Orexin Receptor Type 2 Market Forecast
10.2.1 United States Orexin Receptor Type 2 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.2.2 United States Orexin Receptor Type 2 Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Orexin Receptor Type 2 Forecast by Regions
10.3.1 North America Orexin Receptor Type 2 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.2 Europe Orexin Receptor Type 2 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.3 Asia-Pacific Orexin Receptor Type 2 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.4 South America Orexin Receptor Type 2 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.5 Middle East and Africa Orexin Receptor Type 2 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Orexin Receptor Type 2 Forecast by Type
10.4.1 Global Orexin Receptor Type 2 Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.4.2 United States Orexin Receptor Type 2 Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Orexin Receptor Type 2 Forecast by Application
10.5.1 Global Orexin Receptor Type 2 Sales (K Pcs) Forecast by Application (2018-2025)
10.5.2 United States Orexin Receptor Type 2 Sales (K Pcs) Forecast by Application (2018-2025)

11 Research Findings and Conclusion